Research Insight
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Research Insight sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).
Research Insight: 15 sponsored US clinical trials, 1 recruiting.
Research Insight sponsors 15 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 13 completed. 7 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dry Eye, with 2 trials.
Top-decile sponsor footprint
Research Insight ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
15 total, page 1 of 1
The THINK Study Incidence of Neurotrophic Keratopathy)
NCT06482164
The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
NCT07276802
2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
NCT07144644
The COAT Trial: Cequa's Onset of Action Trial
NCT06482177
The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction
NCT05346172
Cyclosporine 0.1% / Loteprednol 0.2% Effect on Anterior Segment Normalization
NCT05322148
Evaluation of the Accuracy & Safety of the LaserArcs Nomogram
NCT05278442
The DEPOT Study (Dry Eye Prescription Options for Therapy)
NCT04911361
The Chronology of Lifitegrast Effect on Anterior Surface Rehabilitation (CLEAR) Study
NCT04669561
Vivity Insight: A Study of Patient Satisfaction and Visual Performance
NCT04495049
Veracity Surgical: A Time/Motion and Quality of Care Study
NCT04337892
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
NCT04342988
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
NCT04273282
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
NCT04146961
Comparison of Pre-operative Measurements With Intraoperative Aberrometry in Predicting Correction for Low Toric Lens Correction in Cataract Surgery
NCT04247152
Where Research Insight enrollment is open (later-stage tilt)
1 recruiting of 15 indexed (7% open); 13 completed (87%).
Phase mix: 7 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Dry Eye (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Research Insight: open-pipeline peers nationwide
Peers matched on 15 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Research Insight sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 15 trials (± recruiting share)
- Allakos · 15 trials · 0% recruiting
- Arbor Research Collaborative for Health · 15 trials · 33% recruiting
- Arena Pharmaceuticals · 15 trials · 0% recruiting
- Arrowhead Pharmaceuticals · 15 trials · 20% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Baylor Breast Care Center · 7% recruiting · 15 trials
- Geron Corporation · 7% recruiting · 15 trials
- Guerbet · 7% recruiting · 15 trials
- Joanne Kurtzberg, MD · 7% recruiting · 15 trials
Related
What to do with this Research Insight page
15 registered trials is a research-attention snapshot, not an endorsement of Research Insight or any single study.
- 1 of Research Insight's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Dry Eye is the condition Research Insight studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dry Eye trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Research Insight pipeline card: 15 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.